- Bevorzugter Name
- Rociletinib hydrobromide
- IUPAC
- N-[3-[[2-[4-(4-acetylpiperazin-1-yl)-2-methoxyanilino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide;hydrobromide
- Englischer Name
- CNX-419 hydrobroMide
- Summenformel
- C27H29BrF3N7O3
- Molmasse
- 636.47
Namen und Synonyme
CO-1686 hydrobromideRociletinib hydrobromideCNX-419 hydrobroMideCV4XAQ7MUVUNII-CV4XAQ7MUV2-Propenamide, N-[3-[[2-[[4-(4-acetyl-1-piperazinyl)-2-methoxyphenyl]amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]phenyl]-, hydrobromide (1:1)2-Propenamide, N-(3-((2-((4-(4-acetyl-1-piperazinyl)-2-methoxyphenyl)amino)-5-(trifluoromethyl)-4-pyrimidinyl)amino)phenyl)-, hydrobromide (1:1)RefChem:2028891446700-26-0N-[3-[[2-[4-(4-acetylpiperazin-1-yl)-2-methoxyanilino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide;hydrobromideCO-1686 (hydrobromide)Rociletinib HBr
Weitere Namen anzeigen
CO-1686 HBrCNX-419 HBrRociletinib hydrobromide (CO1686Rociletinib (CO-1686,AVL-301) HBrAVL-301 HBr salt, CNX-419 HBr saltCO-1686 HBr salt,Rociletinib HBr salt
Osimertinib-3AVL-301 hydrobromideCO-1686 hydrobromide?C27H29BrF3N7O3orb1707436SCHEMBL30101824IPKRDUJIGYXXNT-UHFFFAOYSA-NEX-A1584